Viridian Therapeutics Inc (VRDN) Gross Profit Margin starting from the first quarter 2026 to first quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Viridian Therapeutics Inc   (NASDAQ: VRDN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Viridian Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



VRDN Gross Profit Margin (Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Mar 31 2025)
Q1
(Dec 31 2024)
Q4
Y / Y Revenue Change 95.83 %
Seq. Revenue Change 16.53 %
Revenue In Millions $0.14
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 598
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting First Quarter 2026 Gross Profit Margin



Observing first quarter 2026 results within Medical Laboratories industry 6 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
VRDN's Gross Profit Margin first quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 153
Overall # 598

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Mar 31 2026)  




Other Gross Profit Margin Profitability Ratios
VRDN's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
VRDN's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for VRDN's Competitors
Gross Profit Margin Profit Margin for Viridian Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for VRDN's Customers

You may also want to know
VRDN's Annual Growth Rates VRDN's Profitability Ratios VRDN's Asset Turnover Ratio VRDN's Dividend Growth
VRDN's Roe VRDN's Valuation Ratios VRDN's Financial Strength Ratios VRDN's Gross Profit Growth
VRDN's Roa VRDN's Inventory Turnover Ratio VRDN's Growth Rates VRDN's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2026, within Medical Laboratories Industry Gross Profit MarginMar 31 2026 MRQ Gross ProfitMar 31 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.